Enterprise Trust & Investment’s Thermo Fisher Scientific TMO Stock Holding History

Enterprise Trust & Investment’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$15K	Buy	+27	New	+$14.9K	0.01%	196

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Enterprise Trust & Investment's TMO Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Thermo Fisher Scientific (TMO) in Q2 2022: 27 shares worth $15K. The stake represents 0.01% of the portfolio and ranks #196 among its holdings.

2,281 funds tracked by Wall St. Rank hold TMO as of Q2 2022.

Enterprise Trust & Investment held 27 shares of Thermo Fisher Scientific worth $15K as of Q2 2022.
Thermo Fisher Scientific was a new Enterprise Trust & Investment position in Q2 2022.
Thermo Fisher Scientific made up 0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #196 holding.
2,281 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.